Status:
UNKNOWN
Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy
Lead Sponsor:
Cairo University
Conditions:
Psoriasis
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
• Assessment of tissue level of resolvin D1 in psoriasis in comparison to its level in healthy controls in order to verify its role in the pathogenesis of psoriasis.
Eligibility Criteria
Inclusion
- Patients with psoriasis (adults and children above 12years)
- Both sexes.
- New cases or cases not receiving any treatment for at least 3 months ago.
Exclusion
- Any contraindication to phototherapy treatment (e.g. Photosensitizing creams or medications, past skin cancer, especially melanoma, etc...)
- Erythrodermic and pustular psoriasis.
- History of autoimmune diseases or other systemic diseases (e.g. Alzheimer's disease, fibromyalgia, cystic fibrosis)
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03483311
Start Date
March 1 2018
End Date
September 1 2018
Last Update
March 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maha Fathy Elmasry
Cairo, Egypt, 11562